Milojkovic D, Cross NCP, Ali S, Byrne J, et al. Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study. Br J Haematol 2021;192:62-74.
PMID: 32449159